Literature DB >> 26201797

Alcoholism worsens the survival of patients with hepatitis B virus and C virus-related hepatocellular carcinoma.

Yun-Hsuan Lee1,2, Chia-Yang Hsu1,2, Cheng-Yuan Hsia3,2, Yi-Hsiang Huang1,4, Chien-Wei Su1,2, Yi-You Chiou5,2, Han-Chieh Lin1,2, Teh-Ia Huo6,7, Shou-Dong Lee2,8.   

Abstract

BACKGROUND/AIMS: Chronic hepatitis B and hepatitis C virus (HBV, HCV) infection and alcoholism are common etiologies for hepatocellular carcinoma (HCC). The characteristics and impact of alcoholism and/or HCV/HBV infection on HBV- and HCV-related HCC, respectively, are investigated in this study.
METHODS: A total of 1,888 patients were retrospectively investigated and categorized into six groups, HBV only (n = 977), HBV with alcoholism (n = 197), HCV only (n = 544), HCV with alcoholism (n = 67), dual HBV and HCV (n = 82), and dual virus with alcoholism (n = 21), to examine their interactions on the outcome.
RESULTS: Compared to their counterparts, alcoholic patients coinfected with HBV and/or HCV tended to be younger, had higher male-to-female ratios, worse performance status, more severe liver cirrhosis, advanced cancer staging, and tumor burden than patients without alcoholism. In survival analysis, patients with HBV with alcoholism had a significantly decreased survival than the HBV-only group (p = 0.001). A shortened survival was also observed in HCV with alcoholism group compared to the HCV-only group (p = 0.011). Dual virus infection with alcoholism did not significantly worsen the survival compared to the dual virus infection group. In the Cox proportional hazards model, HBV with alcoholism group [risk ratio (RR) 1.299, p = 0.032] and HCV with alcoholism (RR 1.523, p = 0.025) group were independent predictors associated with decreased survival compared to their counterpart of HBV- and HCV-only groups.
CONCLUSIONS: Alcoholism in patients with HBV or HCV infection is characterized by early development of HCC with advanced cirrhosis and cancer staging at diagnosis. Alcoholism independently predicts an increased risk of mortality in patients with HBV- and HCV-related HCC.

Entities:  

Keywords:  Alcoholism; Dual virus infection; HBV; HCV; Hepatocellular carcinoma

Year:  2012        PMID: 26201797     DOI: 10.1007/s12072-012-9375-2

Source DB:  PubMed          Journal:  Hepatol Int        ISSN: 1936-0533            Impact factor:   6.047


  39 in total

1.  A new prognostic model for hepatocellular carcinoma based on total tumor volume: the Taipei Integrated Scoring System.

Authors:  Chia-Yang Hsu; Yi-Hsiang Huang; Cheng-Yuan Hsia; Chien-Wei Su; Han-Chieh Lin; Che-Chuan Loong; Yi-You Chiou; Jen-Huey Chiang; Pui-Ching Lee; Teh-Ia Huo; Shou-Dong Lee
Journal:  J Hepatol       Date:  2010-03-31       Impact factor: 25.083

2.  Prevalence and detection of alcohol use disorders among general hospital inpatients in eastern Taiwan.

Authors:  Shu-I Wu; Shen-Ing Liu; Chun-Kai Fang; Chien-Chi Hsu; Yi-Wen Sun
Journal:  Gen Hosp Psychiatry       Date:  2006 Jan-Feb       Impact factor: 3.238

Review 3.  Primary liver cancer: worldwide incidence and trends.

Authors:  F Xavier Bosch; Josepa Ribes; Mireia Díaz; Ramon Cléries
Journal:  Gastroenterology       Date:  2004-11       Impact factor: 22.682

4.  The model for end-stage liver disease-based Japan Integrated Scoring system may have a better predictive ability for patients with hepatocellular carcinoma undergoing locoregional therapy.

Authors:  Teh-Ia Huo; Han-Chieh Lin; Yi-Hsiang Huang; Jaw-Ching Wu; Jen-Huei Chiang; Pui-Ching Lee; Shou-Dong Lee
Journal:  Cancer       Date:  2006-07-01       Impact factor: 6.860

5.  Hepatitis C and hospital outcomes in patients admitted with alcohol-related problems.

Authors:  Judith I Tsui; Mark J Pletcher; Eric Vittinghoff; Karen Seal; Ralph Gonzales
Journal:  J Hepatol       Date:  2005-08-24       Impact factor: 25.083

6.  Alcohol-related problems in Taiwan with particular emphasis on alcoholic liver diseases.

Authors:  J D Liu; K W Leung; C K Wang; L Y Liao; C S Wang; P H Chen; C C Chen; E K Yeh
Journal:  Alcohol Clin Exp Res       Date:  1998-05       Impact factor: 3.455

7.  Synergism of alcohol, diabetes, and viral hepatitis on the risk of hepatocellular carcinoma in blacks and whites in the U.S.

Authors:  Jian-Min Yuan; Sugantha Govindarajan; Kazuko Arakawa; Mimi C Yu
Journal:  Cancer       Date:  2004-09-01       Impact factor: 6.860

Review 8.  The Barcelona approach: diagnosis, staging, and treatment of hepatocellular carcinoma.

Authors:  Josep M Llovet; Josep Fuster; Jordi Bruix
Journal:  Liver Transpl       Date:  2004-02       Impact factor: 5.799

Review 9.  Alcohol, cofactors and the genetics of hepatocellular carcinoma.

Authors:  Mimi C Yu; Jian-Min Yuan; Shelly C Lu
Journal:  J Gastroenterol Hepatol       Date:  2008-03       Impact factor: 4.029

10.  Mortality related to chronic hepatitis B and chronic hepatitis C in France: evidence for the role of HIV coinfection and alcohol consumption.

Authors:  Patrick Marcellin; Françoise Pequignot; Elisabeth Delarocque-Astagneau; Jean-Pierre Zarski; Nathalie Ganne; Patrick Hillon; Denise Antona; Martine Bovet; Murielle Mechain; Tarik Asselah; Jean-Claude Desenclos; Eric Jougla
Journal:  J Hepatol       Date:  2007-11-20       Impact factor: 25.083

View more
  8 in total

Review 1.  Impact of etiological treatment on prognosis.

Authors:  Chien-Wei Su; Ying-Ying Yang; Han-Chieh Lin
Journal:  Hepatol Int       Date:  2017-07-12       Impact factor: 6.047

2.  α-fetoprotein-to-total tumor volume ratio predicts post-operative tumor recurrence in hepatocellular carcinoma.

Authors:  Yun-Hsuan Lee; Chia-Yang Hsu; Yi-Hsiang Huang; Chien-Wei Su; Han-Chieh Lin; Cheng-Yuan Hsia; Teh-Ia Huo
Journal:  J Gastrointest Surg       Date:  2012-11-28       Impact factor: 3.452

3.  Using serum α-fetoprotein for prognostic prediction in patients with hepatocellular carcinoma: what is the most optimal cutoff?

Authors:  Chia-Yang Hsu; Po-Hong Liu; Yun-Hsuan Lee; Cheng-Yuan Hsia; Yi-Hsiang Huang; Han-Chieh Lin; Yi-You Chiou; Fa-Yauh Lee; Teh-Ia Huo
Journal:  PLoS One       Date:  2015-03-04       Impact factor: 3.240

4.  Impact of tumor burden on prognostic prediction for patients with terminal stage hepatocellular carcinoma: A nomogram study.

Authors:  Chia-Yang Hsu; Po-Hong Liu; Shu-Yein Ho; Yi-Hsiang Huang; Yun-Hsuan Lee; Yi-You Chiou; Ting-Hui Hsieh; Tom Fang; Ya-Ju Tsai; Ming-Chih Hou; Teh-Ia Huo
Journal:  PLoS One       Date:  2017-11-10       Impact factor: 3.240

5.  A New Treatment-integrated Prognostic Nomogram of the Barcelona Clinic Liver Cancer System for Hepatocellular Carcinoma.

Authors:  Chia-Yang Hsu; Po-Hong Liu; Cheng-Yuan Hsia; Yun-Hsuan Lee; Teddy S Nagaria; Rheun-Chuan Lee; Shu-Yein Ho; Ming-Chih Hou; Teh-Ia Huo
Journal:  Sci Rep       Date:  2017-08-11       Impact factor: 4.379

Review 6.  Effects of alcohol consumption on viral hepatitis B and C.

Authors:  Hong-Qin Xu; Chun-Guang Wang; Qiang Zhou; Yan-Hang Gao
Journal:  World J Clin Cases       Date:  2021-11-26       Impact factor: 1.337

7.  Decrypting cryptogenic hepatocellular carcinoma: clinical manifestations, prognostic factors and long-term survival by propensity score model.

Authors:  Chia-Yang Hsu; Yun-Hsuan Lee; Po-Hong Liu; Cheng-Yuan Hsia; Yi-Hsiang Huang; Han-Chieh Lin; Yi-You Chiou; Fa-Yauh Lee; Teh-Ia Huo
Journal:  PLoS One       Date:  2014-02-24       Impact factor: 3.240

8.  Using nomogram of the Barcelona Clinic Liver Cancer system for treatment selection in patients with stage C hepatocellular carcinoma.

Authors:  Chia-Yang Hsu; Po-Hong Liu; Shu-Yein Ho; Cheng-Yuan Hsia; Praneeth Kudaravalli; Yun-Hsuan Lee; Yi-You Chiou; Ya-Ju Tsai; Yi-Hsiang Huang; Teh-Ia Huo
Journal:  BMC Cancer       Date:  2018-03-14       Impact factor: 4.430

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.